Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience-Reference-Cited by-同舟云学术

Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience

Published:2013-08-11 Issue:1 Volume:61 Page:95-101
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Zaky Wafik¹,Dhall Girish²,Ji Lingyun³,Haley Kelley²,Allen Jeffrey⁴,Atlas Mark⁵,Bertolone Salvatore⁶,Cornelius Albert⁷,Gardner Sharon⁴,Patel Ramesh⁸,Pradhan Kamnesh⁹,Shen Violet¹⁰,Thompson Stephen¹¹,Torkildson Joseph¹²,Sposto Richard³,Finlay Jonathan L.²

Affiliation:

1. Division of Pediatric Hematology and Oncology, Department of Pediatrics; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Division of Pediatric Hematology and Oncology; Children's Hospital of Los Angeles; Los Angeles California

3. University of Southern California; Los Angeles California

4. Division of Pediatric Hematology and Oncology, Department of Pediatrics; New York Langone University Medical Center; New York New York

5. Division of Pediatric Hematology and Oncology; Schneider Children's Hospital-Long Island Jewish Medical Center; New Hyde Park New York

6. Division of Pediatric Hematology and Oncology; Kosair Children's Hospital; Louisville Kentucky

7. Division of Pediatric Hematology and Oncology; DeVos Children's Hospital; Grand Rapids Michigan

8. Division of Pediatric Hematology and Oncology; Miller Children's Hospital; Long Beach California

9. Division of Pediatric Hematology and Oncology; Riley Children's Hospital; Indianapolis Indiana

10. Division of Pediatric Hematology and Oncology; Children's Hospital of Orange County; Orange California

11. Division of Pediatric Hematology and Oncology; Tomorrow Children's Institute; Hackensack New Jersey

12. Division of Pediatric Hematology and Oncology; Children's Hospital of Oakland & Research Institute; Oakland California

Funder

Soccer for Hope Foundation

Maddie's Closet

Michael Hoefflin Foundation

Pediatric Cancer Research Foundation

Grayson's Gift

Isabelle Grace Jordan fund

Alex's Lemonade Stand Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24648/fullpdf

Reference32 articles.

1. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a surveillance, epidemiology, and end results analysis;Buscariollo;Cancer,2011

2. Frequency, risk factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database;Von Hoff;Pediatr Blood Cancer,2011

3. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a surveillance, epidemiology, and end results analysis;Buscariollo;Cancer,2012

4. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer;Versteege;Nature,1998

5. The Role of INI1 and the SWI/SNF complex in the development of Rhabdoid tumors: Meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors;Biegel;Cancer Res,2002

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review;CNS Oncology;2024-07-23

2. Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single‐institution study with molecular correlation;Pediatric Blood & Cancer;2024-07-21

3. ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs);Radiotherapy and Oncology;2024-07

4. Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors;Cancers;2024-05-28

5. Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse;Journal of Neuro-Oncology;2024-04-19